Global status of the marketing and clinical research involving small nucleic acid drugsDU Hui, XIAO Yu-feng, ZHANG Bin1233-1243
Exploration into the innovative value of development of drugs and medical devices for rare diseasesZHANG Yan-ling, MA Ming-shu, LIANG Yun, SHAO Rong1244-1249
Quantitative analysis of innovation policy texts for biomedical industry in Jiangsu Province based on three-dimensional perspectiveWANG Ming-hui, LI Jun, ZHANG Yi-meng, DONG Fang-zheng, XIE Xin-rong, WU Jing-jing, LÜ Yi, MAO Ning-ying1250-1257
Comparative analysis of ICP-MS and AAS methods for determination of arsenic in clevidipine butyrateSU Hai, ZHANG Wen-jing, ZHUANG Jie, NIU Jian-zhao, LIU Qian1258-1262
The current research status of the classic formula Sini Decoction in the treatment of chronic heart failureWANG Yang, WANG Feng-rong1263-1268
Progress in research on small molecule glucagon-like peptide-1 receptor agonistsZHANG Xin-yi, WANG Tian-min, CHEN Yin-bo, ZHANG Peng, ZHU Xue-yan1269-1275
Exploration of risk control in phase I clinical trials of T cell therapy against cancerFANG Ying-ying, WANG Xing-he1276-1279
Improvement of dissolvability of Tongsaimai granules based on AHP-CRITIC weight analysis and mixing design methodWANG Sheng-hua, WANG Shu-juan, YAN Ming, WANG Xin, ZHANG Chen-feng, WANG Zhen-zhong, ZHOU En-li, XIAO Wei1280-1288
Research of carcinogenic risk assessment for Pb and As in pheretima and scorpio based on in vitro PBET digestion/Caco-2 cell modelZUO Tian-tian, XIE Si-min, JIN Hong-yu, LIU Jing, CHENG Xian-long, WEI Feng1289-1295
Preliminary evaluation of quality stability of oral trivalent reformulated live attenuated rotavirus vaccine(Vero cell)TONG Yan-jun, FU Shu-guang, CHEN Tong, FENG Jiao-li, LIU Xiang-peng, ZHANG Jian-bin, LI Jia-lin1296-1301